CHRO Chromocell Therapeutics Corp

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Chromocell Therapeutics Corp. market cap is $10.6M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Chromocell Therapeutics Corp. 52 week high is $6.00 as of May 08, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Chromocell Therapeutics Corp. 52 week low is $1.21 as of May 08, 2024.

Chromocell Therapeutics Corp. stock price today is $1.84.

Chromocell Therapeutics Corp. stock price yesterday was $1.66.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Chromocell Therapeutics Corp.’s P/E ratio is -1.45.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Chromocell Therapeutics Corp. P/B ratio is -1.6754.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Chromocell Therapeutics Corp.'s EBITDA is N/A.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Chromocell Therapeutics Corp. 50-day moving average is $2.48.

Chromocell Therapeutics Corp. has 8 employees.